This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunk, C. Articles by Ahmed, A. Search for Related Content PubMed PubMed Citation Articles by Dunk, C. Articles by Ahmed, A.

(American Journal of Pathology. 2001;158:265-273.)
© 2001 American Society for Investigative Pathology

Regular Articles

Vascular Endothelial Growth Factor Receptor-2-Mediated Mitogenesis Is Negatively Regulated by Vascular Endothelial Growth Factor Receptor-1 in Tumor Epithelial Cells

From the Department of Reproductive and Vascular Biology, Division of Reproductive and Child Health, The Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom

Vascular endothelial growth factor (VEGF) receptors are present on nonendothelial cells suggesting that VEGF may mediate nonendothelial effects during organogenesis and tumorigenesis. Here we show that VEGF receptor-1 (VEGFR-1) negatively regulates VEGFR-2-mediated proliferation via nitric oxide (NO) in an epithelial cancer cell line ECV304. Cell proliferation was assessed by [³H]thymidine incorporation, fluorescent-activated cell-sorting analysis, and cell number using a Coulter Counter. Total NO generated by the action of nitric oxide synthase was measured by Seivers NOA 280 Nitric Oxide Chemiluminescence Analyser. VEGF (1 ng/ml) stimulated DNA synthesis and increased ECV304 cell number in a manner that was inhibited by a neutralizing anti-VEGFR-2 antibody. In contrast, VEGF (50 ng/ml) stimulated NO release in a manner that was inhibited by functionally neutralizing anti-VEGFR-1 antibody. Blockage of the VEGFR-1 receptor signal with anti-VEGFR-1 stimulated DNA synthesis and increased cell number. Cell-cycle analysis showed that inhibition of VEGFR-1 increased the transition from G₁ to S phase whereas inhibition of VEGFR-2 blocked the VEGF-mediated transition from G₁ to S phase. Finally, the addition of NO donors suppressed both VEGF-mediated proliferation and the increase in growth after blockade of VEGFR-1. Conversely, inhibition of VEGF mediated NO release by nitric oxide synthase inhibitor, L-monomethyl-L-arginine, restored the mitogenic effect of VEGF. These findings identify a dose-dependent reciprocal regulatory mechanism for VEGF via its two receptors. It shows that VEGFR-1 induces cell cytostasis via NO and as such is a suitable target for molecular strategies suppressing tumorigenesis.

This article has been cited by other articles:

				H. T. Yuan, S. Venkatesha, B. Chan, U. Deutsch, T. Mammoto, V. P. Sukhatme, A. S. Woolf, and S. A. Karumanchi Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival FASEB J, October 1, 2007; 21(12): 3171 - 3183. [Abstract] [Full Text] [PDF]

				S. E. Holloway, A. W. Beck, L. Shivakumar, J. Shih, J. B. Fleming, and R. A. Brekken Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts Ann. Surg. Oncol., August 1, 2006; 13(8): 1145 - 1155. [Abstract] [Full Text] [PDF]

				T. A. Wilgus, A. M. Matthies, K. A. Radek, J. V. Dovi, A. L. Burns, R. Shankar, and L. A. DiPietro Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal Keratinocytes Am. J. Pathol., November 1, 2005; 167(5): 1257 - 1266. [Abstract] [Full Text] [PDF]

				D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]

				T. T. Rissanen, J. E. Markkanen, M. Gruchala, T. Heikura, A. Puranen, M. I. Kettunen, I. Kholova, R. A. Kauppinen, M. G. Achen, S. A. Stacker, et al. VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses Circ. Res., May 30, 2003; 92(10): 1098 - 1106. [Abstract] [Full Text] [PDF]

				T. P. Boesen, B. Soni, T. W. Schwartz, and T. Halkier Single-chain Vascular Endothelial Growth Factor Variant with Antagonist Activity J. Biol. Chem., October 18, 2002; 277(43): 40335 - 40341. [Abstract] [Full Text] [PDF]

				B. Bussolati, C. Dunk, M. Grohman, C. D. Kontos, J. Mason, and A. Ahmed Vascular Endothelial Growth Factor Receptor-1 Modulates Vascular Endothelial Growth Factor-Mediated Angiogenesis via Nitric Oxide Am. J. Pathol., September 1, 2001; 159(3): 993 - 1008. [Abstract] [Full Text] [PDF]

				O. Straume and L. A. Akslen Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas Am. J. Pathol., July 1, 2001; 159(1): 223 - 235. [Abstract] [Full Text] [PDF]